Ernesto Bosch, M. D. , Elena Labarta, M. D

Slides:

Advertisements

Similar presentations

A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer William M. Buckett, M.D. Fertility and Sterility

Advertisements

Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis George Griesinger, M.D.,

A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage.

Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage

Age at menarche: a predictor of diminished ovarian function?

Soyoung Bae, M.D., Joseph Karnitis, M.D. Fertility and Sterility

Oral contraceptive pretreatment significantly reduces ongoing pregnancy likelihood in gonadotropin-releasing hormone antagonist cycles: an updated meta-analysis

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase Michael von Wolff, M.D., Christian J. Thaler,

Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis Ioannis P. Kosmas, M.D.,

Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials Ana Cobo, Ph.D., César Diaz, M.D.

Zhi-Yong Yang, M.D., Ri-Cheng Chian, Ph.D. Fertility and Sterility

The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.

A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer

Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D

Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study Nicole Hope, M.B., B.S., Hon., Luk.

Initial experience with a risk-sharing in vitro fertilization–embryo transfer program with novel features Jacques P. Stassart, M.D., Romaine B. Bayless,

Aviad Cohen, M.D., Benny Almog, M.D., Togas Tulandi, M.D., M.H.C.M.

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

Primary hyperparathyroidism in pregnancy

Triploidy formation after intracytoplasmic sperm injection may be a surrogate marker for implantation Mitchell P. Rosen, M.D., Shehua Shen, M.D., Anthony.

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Oocyte cryopreservation

Effects of acupuncture on pregnancy rates in women undergoing in vitro fertilization: a systematic review and meta-analysis Cui Hong Zheng, M.D., Ph.D.,

Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study Ahmet Erdem, M.D., Mehmet Erdem,

Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),

I. Dimitriadis, G. Y. Christou, K. A. Dickinson, M. Thatcher, C. L

A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone

Effect of Salpingectomy on Ovarian Reserve: A Systematic Review and Meta-Analysis C.E. Boots, MD, E.A. Seidler, MD, A. Ainsworth, MD, A. Hardi, MLIS,

Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement Fertility and Sterility Volume 102,

A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin.

David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D.

Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation Nam D. Tran, M.D., Ph.D., Lusine Aghajanova, M.D.,

How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis Dimitra Kyrou,

From partner's desk to iPad

Fertility and Sterility

What are patients doing with their mosaic embryos

Mark A. Zakaria, M. D. , Mazen E. Abdallah, M. D. , Valerie I

Mitchell P. Rosen, M. D. , Erica Johnstone, M. D. , Charles E

Tiffany D. Justice, M.D., Steven T. Nakajima, M.D.

Nondominant small follicles are a promising source of mature oocytes in modified natural cycle in vitro fertilization and embryo transfer Shokichi Teramoto,

Endometrial morphology and modulation of hormone receptors during ovarian stimulation for assisted reproductive technology cycles Laura Detti, M.D.,

Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis.

Poor sperm quality affects clinical outcomes of intracytoplasmic sperm injection in fresh and subsequent frozen–thawed cycles: potential paternal effects.

Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis

A. Criniti, G. Chow, A. Khabani, L. Scott, N.A. Klein

Live babies born per oocyte retrieved in a subpopulation of oocyte donors with repetitive reproductive success J. Ryan Martin, M.D., Jason G. Bromer,

Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone.

Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D.

Fertility and Sterility

A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation

Luteal support with intravaginal progesterone increases clinical pregnancy rates in women with polycystic ovary syndrome using letrozole for ovulation.

Bruce S Shapiro, M. D. , Kevin S Richter, Ph. D. , Dee C Harris, M. T

S. Samuel Kim, M.D. Fertility and Sterility

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D.

Failed IVF cycles and the risk of subsequent preeclampsia or fetal growth restriction: a case-control exploratory study Ioanna Tsoumpou, M.D., Ahmed.

Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization Efstratios M Kolibianakis, M.D., Kostas.

Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis Ernesto Bosch, M.D., Elena.

A review and meta-analysis of prospective trials comparing different catheters used for embryo transfer William M. Buckett, M.D. Fertility and Sterility

Fertility and Sterility

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Transfer of two versus three embryos in women less than 40 years old undergoing frozen transfer cycles Inna Berin, M.D., Lawrence L. Engmann, M.D., Claudio.

Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function David H. Barad, M.D., M.S., Andrea Weghofer,

Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories Melissa C. Yih, M.D.,

In vitro sildenafil citrate use as a sperm motility stimulant

Fertility and Sterility

A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders Hakan Cakmak, M.D., Nam D. Tran,

Presentation transcript:

Regimen of ovarian stimulation affects oocyte and therefore embryo quality Ernesto Bosch, M.D., Elena Labarta, M.D., Efstratios Kolibianakis, M.D., Mitchell Rosen, M.D., David Meldrum, M.D. Fertility and Sterility Volume 105, Issue 3, Pages 560-570 (March 2016) DOI: 10.1016/j.fertnstert.2016.01.022 Copyright © 2016 Terms and Conditions

Figure 1 Risk difference (RD) for clinical pregnancy (11% higher) between patients treated with FSH and GH and those treated with FSH only. Fertility and Sterility 2016 105, 560-570DOI: (10.1016/j.fertnstert.2016.01.022) Copyright © 2016 Terms and Conditions

Figure 2 Risk difference (RD) for the proportion of patients reaching ET (14% higher) between those treated with FSH and GH and those treated with FSH only. Fertility and Sterility 2016 105, 560-570DOI: (10.1016/j.fertnstert.2016.01.022) Copyright © 2016 Terms and Conditions